Abstract. – Objective: To compare the pregnancy outcome in patients undergoing in vitro fertilization-embryo transfer (IVF-ET) cycles, using human derived follicle-stimulating hormone (FSH) or recombinant FSH for ovarian stimulation protocols.
Design: Prospective, multi-centre, randomized controlled trial.
Patients: 115 infertile patients undergoing a first attempt of in vitro fertilization and embryo transfer were included in the study. The inclusion criteria were: female age Interventions: Long Protocol-controlled ovarian stimulation with human derived FSH or recombinant FSH for IVF-ET.
Main Outcome Measures: Primary end-points were implantation rate, clinical pregnancy rate and spontaneous abortion rate.
Secondary end-points were total units of FSH injected, days of stimulation, peak estradiol levels at point of hCG administration, mean number of oocytes at pick-up, fertilization rate and cleavage rate.
Results: No statistically significantly differences in pregnancy outcomes were found in the patients receiving hFSH in comparison to patients receiving rFSH.
Conclusions: This study did not demonstrate a difference between the use of h-FSH vs r-FSH for ovarian stimulation in terms of pregnancy outcome, in good prognosis patients undergoing their first IVF-ET procedure.
Corresponding Author: Hossein Gholami, MD; e-mail: firstname.lastname@example.orgFree PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
H. Gholami*, E. Vicari°, M. Molis†, S. La Vignera°, E. Papaleo§, F. Cappiello†
Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women aged <37, undergoing ovulation induction with human FSH compared with recombinant FSH: a randomised controlled study
Eur Rev Med Pharmacol Sci
Vol. 14 - N. 2